BREAST PATHOLOGY

Demystifying basal-like breast carcinomas

L Da Silva, C Clarke and S R Lakhani

Molecular & Cellular Pathology, School of Medicine, University of Queensland; The Queensland Institute of Medical Research; and Queensland Health Pathology Services, The Royal Brisbane & Women’s Hospital, Brisbane, Australia

Correspondence to:
Professor S R Lakhani, Molecular and Cellular Pathology, School of Medicine, The University of Queensland, Mayne Medical School, Herston Rd, Herston QLD 4006, Australia; s.lakhani{at}uq.edu.au

"Basal" breast cancers are dominating the breast research literature at present and pathologists are under increasing pressure to evaluate for such a phenotype by their surgical and oncological colleagues. There is also much confusion about how to assess cancers, which immunohistochemical markers to use, what meaning and benefit this provides, and what the surgeons and oncologists will do with the information. Much remains to be done to answer all these questions but here we try to shed light on some of the issues and suggest what is still to come.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Schade, B., Rao, T., Dourdin, N., Lesurf, R., Hallett, M., Cardiff, R. D., Muller, W. J. (2009). PTEN Deficiency in a Luminal ErbB-2 Mouse Model Results in Dramatic Acceleration of Mammary Tumorigenesis and Metastasis. J. Biol. Chem. 284: 19018-19026 [Abstract] [Full Text]  
• Pintens, S, Neven, P, Drijkoningen, M, Van Belle, V, Moerman, P, Christiaens, M-R, Smeets, A, Wildiers, H, Bempt, I V. (2009). Triple negative breast cancer: a study from the point of view of basal CK5/6 and HER-1. J. Clin. Pathol. 62: 624-628 [Abstract] [Full Text]  
• Spitale, A., Mazzola, P., Soldini, D., Mazzucchelli, L., Bordoni, A. (2009). Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland. Ann Oncol 20: 628-635 [Abstract] [Full Text]  
• Klinakis, A., Szabolcs, M., Chen, G., Xuan, S., Hibshoosh, H., Efstratiadis, A. (2009). Igf1r as a therapeutic target in a mouse model of basal-like breast cancer. Proc. Natl. Acad. Sci. USA 106: 2359-2364 [Abstract] [Full Text]  
• Manie, E., Vincent-Salomon, A., Lehmann-Che, J., Pierron, G., Turpin, E., Warcoin, M., Gruel, N., Lebigot, I., Sastre-Garau, X., Lidereau, R., Remenieras, A., Feunteun, J., Delattre, O., de The, H., Stoppa-Lyonnet, D., Stern, M.-H. (2009). High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors. Cancer Res. 69: 663-671 [Abstract] [Full Text]  
• Garcia-Closas, M., Chanock, S. (2008). Genetic Susceptibility Loci for Breast Cancer by Estrogen Receptor Status. Clin. Cancer Res. 14: 8000-8009 [Abstract] [Full Text]  
• Dourdin, N., Schade, B., Lesurf, R., Hallett, M., Munn, R. J., Cardiff, R. D., Muller, W. J. (2008). Phosphatase and Tensin Homologue Deleted on Chromosome 10 Deficiency Accelerates Tumor Induction in a Mouse Model of ErbB-2 Mammary Tumorigenesis. Cancer Res. 68: 2122-2131 [Abstract] [Full Text]